[AACR]
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma
Authors£ºWenjuan Zhang; Rachael A. Vaubel; Ju-Hee Oh; Ann C. Mladek; Surabhi Talele; Wenqiu Zhang; Katie L. Waller; Danielle M. Burgenske; Jann N. Sarkaria; William F. Elmquist